This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Nicole-Claudia Meisner: Innovator in mRNA Research
Introduction
Nicole-Claudia Meisner is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of molecular biology, particularly in the area of mRNA research. Her innovative work has led to the development of a patented method that has the potential to impact therapeutic strategies.
Latest Patents
Nicole-Claudia Meisner holds a patent for a method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein. This invention provides a method for identifying agents that inhibit the complex formation between ARE-containing mRNA and HuR protein. This research is crucial for understanding the regulation of gene expression and its implications in various diseases.
Career Highlights
Nicole-Claudia Meisner is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to collaborate with other experts in the field, enhancing her research and innovation capabilities.
Collaborations
Some of her notable coworkers include Volker Uhl and Manfred Auer. Their collaboration has contributed to advancing research in the field of mRNA and protein interactions.
Conclusion
Nicole-Claudia Meisner is a trailblazer in the field of mRNA research, with her patented method showcasing her innovative spirit. Her work at Novartis AG and collaborations with esteemed colleagues further highlight her contributions to science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile